JPWO2022210784A1 - - Google Patents

Info

Publication number
JPWO2022210784A1
JPWO2022210784A1 JP2022546133A JP2022546133A JPWO2022210784A1 JP WO2022210784 A1 JPWO2022210784 A1 JP WO2022210784A1 JP 2022546133 A JP2022546133 A JP 2022546133A JP 2022546133 A JP2022546133 A JP 2022546133A JP WO2022210784 A1 JPWO2022210784 A1 JP WO2022210784A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022546133A
Other versions
JP7175431B1 (ja
JPWO2022210784A5 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2022210784A1 publication Critical patent/JPWO2022210784A1/ja
Priority to JP2022178888A priority Critical patent/JP7273235B2/ja
Application granted granted Critical
Publication of JP7175431B1 publication Critical patent/JP7175431B1/ja
Publication of JPWO2022210784A5 publication Critical patent/JPWO2022210784A5/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP2022546133A 2021-03-30 2022-03-29 ヘテロシクリデンアセトアミド誘導体含有懸濁液 Active JP7175431B1 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022178888A JP7273235B2 (ja) 2021-03-30 2022-11-08 ヘテロシクリデンアセトアミド誘導体含有懸濁液

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021057713 2021-03-30
JP2021057713 2021-03-30
PCT/JP2022/015691 WO2022210784A1 (ja) 2021-03-30 2022-03-29 ヘテロシクリデンアセトアミド誘導体含有懸濁液

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022178888A Division JP7273235B2 (ja) 2021-03-30 2022-11-08 ヘテロシクリデンアセトアミド誘導体含有懸濁液

Publications (3)

Publication Number Publication Date
JPWO2022210784A1 true JPWO2022210784A1 (ja) 2022-10-06
JP7175431B1 JP7175431B1 (ja) 2022-11-18
JPWO2022210784A5 JPWO2022210784A5 (ja) 2023-02-28

Family

ID=83459508

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2022546133A Active JP7175431B1 (ja) 2021-03-30 2022-03-29 ヘテロシクリデンアセトアミド誘導体含有懸濁液
JP2022178888A Active JP7273235B2 (ja) 2021-03-30 2022-11-08 ヘテロシクリデンアセトアミド誘導体含有懸濁液
JP2023073689A Pending JP2023099107A (ja) 2021-03-30 2023-04-27 ヘテロシクリデンアセトアミド誘導体含有懸濁液

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2022178888A Active JP7273235B2 (ja) 2021-03-30 2022-11-08 ヘテロシクリデンアセトアミド誘導体含有懸濁液
JP2023073689A Pending JP2023099107A (ja) 2021-03-30 2023-04-27 ヘテロシクリデンアセトアミド誘導体含有懸濁液

Country Status (8)

Country Link
EP (1) EP4316485A1 (ja)
JP (3) JP7175431B1 (ja)
KR (1) KR20230163502A (ja)
CN (1) CN117120048A (ja)
AU (1) AU2022250028A1 (ja)
BR (1) BR112023019820A2 (ja)
CA (1) CA3215750A1 (ja)
WO (1) WO2022210784A1 (ja)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61164725A (ja) 1985-01-11 1986-07-25 Inoue Japax Res Inc ワイヤ電極案内
JPH07304663A (ja) * 1994-03-18 1995-11-21 Senju Pharmaceut Co Ltd 眼圧降下用点眼剤
JP3402195B2 (ja) * 1997-05-14 2003-04-28 千寿製薬株式会社 再分散性の良い水性懸濁液剤
BRPI0613771B1 (pt) 2005-07-22 2021-11-23 Mochida Pharmaceutical Co., Ltd Composto derivado de heterociclideno acetamida, composição farmacêutica e antagonista de receptor de tipo i vaniloide com potencial de receptor transitório (trpv1)
JP6230743B1 (ja) * 2017-05-31 2017-11-15 持田製薬株式会社 ヘテロシクリデンアセトアミド誘導体の結晶
CN112409191A (zh) 2019-08-23 2021-02-26 持田制药株式会社 光学活性的氨基醇的制备方法
WO2021039023A1 (ja) 2019-08-23 2021-03-04 持田製薬株式会社 ヘテロシクリデンアセトアミド誘導体の製造方法
KR20240049646A (ko) * 2019-08-27 2024-04-16 산텐 세이야꾸 가부시키가이샤 디쿠아포솔 또는 그 염 및 폴리비닐피롤리돈을 함유하는 수성 안과용 조성물
JP7419728B2 (ja) 2019-09-27 2024-01-23 ブラザー工業株式会社 通信装置と通信装置のためのコンピュータプログラム
CA3156484A1 (en) * 2019-10-04 2021-04-08 Senju Pharmaceutical Co., Ltd. PHARMACEUTICAL MEDICINAL PRODUCT CONTAINING A HETEROCYCLIDENE ACETAMIDE DERIVATIVE

Also Published As

Publication number Publication date
JP2023099107A (ja) 2023-07-11
CN117120048A (zh) 2023-11-24
EP4316485A1 (en) 2024-02-07
CA3215750A1 (en) 2022-10-06
KR20230163502A (ko) 2023-11-30
JP7175431B1 (ja) 2022-11-18
WO2022210784A1 (ja) 2022-10-06
AU2022250028A1 (en) 2023-11-16
JP2023011898A (ja) 2023-01-24
BR112023019820A2 (pt) 2023-11-07
JP7273235B2 (ja) 2023-05-12

Similar Documents

Publication Publication Date Title
BR112023005462A2 (ja)
BR112023012656A2 (ja)
BR112021014123A2 (ja)
BR112022024743A2 (ja)
BR112022009896A2 (ja)
BR102021007058A2 (ja)
BR102020022030A2 (ja)
BR112023011738A2 (ja)
BR112023016292A2 (ja)
BR112023004146A2 (ja)
BR112023011539A2 (ja)
BR112023011610A2 (ja)
BR112023008976A2 (ja)
BR112023009656A2 (ja)
BR112023006729A2 (ja)
BR102021020147A2 (ja)
BR102021018926A2 (ja)
BR102021015247A2 (ja)
BR102021015220A2 (ja)
BR102021014056A2 (ja)
BR102021014044A2 (ja)
BR102021013929A2 (ja)
BR112021017747A2 (ja)
BR102021012230A2 (ja)
BR102021012107A2 (ja)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220728

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220728

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20220728

AA64 Notification of invalidation of claim of internal priority (with term)

Free format text: JAPANESE INTERMEDIATE CODE: A241764

Effective date: 20220810

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20220829

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20221012

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221020

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20221102

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20221108

R150 Certificate of patent or registration of utility model

Ref document number: 7175431

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: R3D04